BioWorld：Inxmed raises $50M to develop cancer therapy in the US, China

Categories:Media Coverage
Author:
Origin:
Time of issue:2022-03-17 14:14
Views:

BioWorld：Inxmed raises $50M to develop cancer therapy in the US, China

Categories:Media Coverage
Author:
Origin:
Time of issue:2022-03-17 14:14
Views:

Information

March 9, 2022

By Doris Yu

Inxmed Co. Ltd. has raised $50 million in a series B round to support clinical trials of its lead candidate, IN-10018, for the treatment of multiple cancers in both the U.S. and China. Inxmed plans to use the funds to invest in trials of IN-10018, bring more stroma-targeting candidates into clinic trials, and improve the firm’s R&D capabilities.

If you need more information, pls refer to the below link:

https://www.bioworld.com/articles/516796-inxmed-raises-50m-to-develop-cancer-therapy-in-the-us-china

Previous: None

Next: Dialogue | interview with Dr. Wang Zaiqi, chairman of the Organizing Committee of the 5th dia China Pharmaceutical R & D Innovation Conference in 2009

Previous: None

Next: Dialogue | interview with Dr. Wang Zaiqi, chairman of the Organizing Committee of the 5th dia China Pharmaceutical R & D Innovation Conference in 2009